2025/04/29
We are proud to announce the closure of an oversubscribed Pre-Series A funding round, backed by leading investors including HEMEX, Zürcher Kantonalbank, Excellis, EFI Lake Geneva Ventures, and Club degli Investitori.
With this support—alongside ongoing funding from Horizon Europe and Innosuisse—Annaida is accelerating the development of its pioneering Micro-MRS technology, bringing new possibilities to science and medicine.